US 11,866,401 B2
Salicyl fumarate derivative and its application in the treatment of Parkinson's disease and other neurodegenerative diseases
Lichuan Yang, New York, NY (US); Bobby Thomas, Augusta, GA (US); and Mingyue Guo, Chongqing (CN)
Assigned to CHONGQING NEUROPARK BIOSCIENCE CO., LTD., Chongqing (CN)
Filed by CHONGQING NEUROPARK BIOSCIENCE CO., LTD., Chongqing (CN)
Filed on Nov. 27, 2020, as Appl. No. 17/105,948.
Application 17/105,948 is a continuation of application No. 16/485,487, abandoned, previously published as PCT/CN2018/078618, filed on Mar. 9, 2018.
Claims priority of application No. 201710191351.9 (CN), filed on Mar. 28, 2017.
Prior Publication US 2021/0179533 A1, Jun. 17, 2021
Int. Cl. C07C 69/60 (2006.01)
CPC C07C 69/60 (2013.01) 2 Claims
 
1. A method comprising applying a salicyl fumarate derivative to drug production for the treatment of Parkinson's Disease, wherein the salicyl fumarate derivative is methyl salicyl fumarate having the below structural formula:

OG Complex Work Unit Chemistry
wherein R1 is one of H30 , Na+, K+or NH4+.